New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has asked patients and doctors to report adverse events suspected to be associated with the use of Absorb Bioresorbable Vascular Scaffold (BVS) and Absorb GTl Bioresorbable Vascular Scaffold (BVS) to the manufacturer (US-based Abbott Vascular), importer (Abbott Healthcare) and the CDSCO. more

- + Advocate Tariq on Can a non-surgeon doctor perform surgery?
- + Pankaj on Forget coloured lenses; now get blue or green eyes
- + Chaitanya on Dr Vikram Shah 'revolutionises' total knee replacement surgery with ‘zero technique’
- + Rajesh on SealBio: A promising new technique of root canal treatment by indigenous stem cells
- + Dr Pranay Shah | Wellspring IVF on No benefit in IVF from routinely freezing all embryos before transfer
Interview: Stem cells have huge potential but must be handled with care
Dr Indumathi Mariappan Research Scientist, Stem Cell Biology Lab L V Prasad Eye Institute, Hyderabad